2,500
Participants
Start Date
September 1, 2025
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2027
Policlinico di Milano Ospedale Maggiore, Milan
Mario Negri Institute for Pharmacological Research
OTHER